📖
wiki page

payload-ketone-body-therapeutic-strategy

📖 Wiki Page
general1012 wordssynced 2026-04-02

Ketone Body Therapeutic Strategy for Neurodegeneration

Overview

This therapeutic approach exploits exogenous ketone body supplementation (beta-hydroxybutyrate [BHB], medium-chain triglycerides [MCTs]) as an alternative cerebral energy substrate to counteract the glucose hypometabolism characteristic of Alzheimer's disease, Parkinson's disease, FTD, and aging[@su2020]. By providing an alternative fuel source that bypasses defective glucose metabolism, ketone bodies can restore neuronal energy, reduce oxidative stress, and attenuate neuroinflammation.

Rationale

Energy Substrate Shift

  • Glucose hypometabolism is universal in neurodegeneration: AD brains show 20-45% reduced glucose utilization decades before symptoms[@su2020]
  • Mitochondrial dysfunction is a core feature across AD/Parkinson's/FTD, limiting ATP production from glucose
  • Ketone bodies bypass glycolysis: BHB enters mitochondria directly via monocarboxylate transporters, generating ATP independently of complex I and II
  • Neuronal survival requires ATP: Even modest ATP restoration can preserve synaptic function and prevent apoptosis

Neuroprotective Mechanisms


...
📖 View canonical wiki page →
Related Entities
ideas-payload-ketone-body-therapeutic-strategy
View on SciDEX ↗